- Filed
- Mar 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 13, 2025 | 979.95M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 979.95M sh |
| Capex restated | FY 2024 · Dec 31, 2023 | $11.34M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$15.98M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $12.95M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $9.03M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $13.18M |
| Current Assets | FY 2024 · Dec 31, 2023 | $99.88M |
| Total Assets | FY 2024 · Dec 31, 2023 | $253.2M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$0.04 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$0.04 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $5.74M |
| Net Income | FY 2024 · Dec 31, 2023 | −$34.53M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$43.28M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $17.32M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $7.87M |
| Revenue | FY 2024 · Dec 31, 2023 | $25.19M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $267.39M |